Stem Cell Marker CD133 Affects Clinical Outcome in Glioma Patients

2008 ◽  
Vol 14 (1) ◽  
pp. 123-129 ◽  
Author(s):  
F. Zeppernick ◽  
R. Ahmadi ◽  
B. Campos ◽  
C. Dictus ◽  
B. M. Helmke ◽  
...  
2010 ◽  
Author(s):  
Christopher A. Scannell ◽  
Diana Abdueva ◽  
Lingyun Ji ◽  
Cornelia von Levetzow ◽  
Richard Sposto ◽  
...  

2009 ◽  
Vol 55 (3) ◽  
pp. 284-293 ◽  
Author(s):  
Qi Wang ◽  
Zhi-Guo Chen ◽  
Chang-Zheng Du ◽  
Hong-Wei Wang ◽  
Li Yan ◽  
...  

2008 ◽  
Vol 1 (3) ◽  
pp. 95-105
Author(s):  
Arpitha P. ◽  
Prajna N. V. ◽  
Srinivasan M. ◽  
Muthukkaruppan V. R.

PROTEOMICS ◽  
2021 ◽  
pp. 2000098
Author(s):  
Annalisa L.E. Carli ◽  
Shoukat Afshar‐Sterle ◽  
Alin Rai ◽  
Haoyun Fang ◽  
Ryan O'Keefe ◽  
...  

2021 ◽  
Vol 53 (1) ◽  
pp. 1-7
Author(s):  
Jinyoung Lee ◽  
Yongcheol Cho

AbstractAxon regeneration is orchestrated by many genes that are differentially expressed in response to injury. Through a comparative analysis of gene expression profiling, injury-responsive genes that are potential targets for understanding the mechanisms underlying regeneration have been revealed. As the efficiency of axon regeneration in both the peripheral and central nervous systems can be manipulated, we suggest that identifying regeneration-associated genes is a promising approach for developing therapeutic applications in vivo. Here, we review the possible roles of stem cell marker- or stemness-related genes in axon regeneration to gain a better understanding of the regeneration mechanism and to identify targets that can enhance regenerative capacity.


2010 ◽  
Vol 29 (4) ◽  
pp. 761-775 ◽  
Author(s):  
Phulwinder K. Grover ◽  
Jennifer E. Hardingham ◽  
Adrian G. Cummins

Sign in / Sign up

Export Citation Format

Share Document